Literature DB >> 17659530

Hypoglycemia, brain energetics, and hypoglycemic neuronal death.

Sang Won Suh1,2, Aaron M Hamby1,2, Raymond A Swanson1,2.   

Abstract

Hypoglycemia is a common and serious problem among diabetic patients receiving treatment with insulin or other glucose-lowering drugs. Moderate hypoglycemia impairs neurological function, and severe hypoglycemia leads to death of selectively vulnerable neurons. Recent advances have shed new light on the underlying processes that cause neuronal death in hypoglycemia and the factors that may render specific neuronal populations especially vulnerable to hypoglycemia. In addition to its clinical importance, the pathophysiology of hypoglycemia is an indicator of the unique bioenergetic properties of the central nervous system, in particular the metabolic coupling of neuronal and astrocyte metabolism. This review will focus on relationships between bioenergetics and brain dysfunction in hypoglycemia, the neuronal cell death program triggered by hypoglycemia, and the role of astrocytes in these processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659530     DOI: 10.1002/glia.20440

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   8.073


  65 in total

1.  Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

Authors:  Julie M Silverstein; Daniel Musikantow; Erwin C Puente; Dorit Daphna-Iken; Adam J Bree; Simon J Fisher
Journal:  Neurosci Lett       Date:  2011-01-25       Impact factor: 3.046

Review 2.  NAD+ depletion or PAR polymer formation: which plays the role of executioner in ischaemic cell death?

Authors:  C Siegel; L D McCullough
Journal:  Acta Physiol (Oxf)       Date:  2011-01-19       Impact factor: 6.311

Review 3.  Diabetes and epilepsy in children and adolescents.

Authors:  M Loredana Marcovecchio; Marianna Immacolata Petrosino; Francesco Chiarelli
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

4.  Death during intensive glycemic therapy of diabetes: mechanisms and implications.

Authors:  Philip E Cryer
Journal:  Am J Med       Date:  2011-11       Impact factor: 4.965

5.  Multicenter Observational Study of the First-Generation Intravenous Blood Glucose Monitoring System in Hospitalized Patients.

Authors:  Grant V Bochicchio; Brian R Hipszer; Michelle F Magee; Richard M Bergenstal; Anthony P Furnary; Angela M Gulino; Michael J Higgins; Peter C Simpson; Jeffrey I Joseph
Journal:  J Diabetes Sci Technol       Date:  2015-06-01

6.  Astrocytic glycogen-derived lactate fuels the brain during exhaustive exercise to maintain endurance capacity.

Authors:  Takashi Matsui; Hideki Omuro; Yu-Fan Liu; Mariko Soya; Takeru Shima; Bruce S McEwen; Hideaki Soya
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-17       Impact factor: 11.205

Review 7.  Mitochondrial dysfunction induced by nuclear poly(ADP-ribose) polymerase-1: a treatable cause of cell death in stroke.

Authors:  Paul Baxter; Yanting Chen; Yun Xu; Raymond A Swanson
Journal:  Transl Stroke Res       Date:  2013-09-07       Impact factor: 6.829

Review 8.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction.

Authors:  Thomas Duning; Ingeborg van den Heuvel; Annabelle Dickmann; Thomas Volkert; Carola Wempe; Julia Reinholz; Hubertus Lohmann; Hendrik Freise; Björn Ellger
Journal:  Diabetes Care       Date:  2009-12-23       Impact factor: 19.112

10.  Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia.

Authors:  Erwin C Puente; Julie Silverstein; Adam J Bree; Daniel R Musikantow; David F Wozniak; Susan Maloney; Dorit Daphna-Iken; Simon J Fisher
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.